Precision Medical Devices & Industrial Dispensing Equipment
Strategic Profile
Medmix operates through two business segments: Healthcare and Consumer & Industrial, leveraging over 900 active patents and strong brand portfolio including Mixpac, Transcodent, and Cox. The company is positioned as a technology-driven provider with global scale, proximity to key customers, and demonstrated capability to serve highly regulated healthcare markets alongside industrial applications.
Cyborg Score Rationale
Medmix benefits from leading market positions, strong IP portfolio, and exposure to growing healthcare and industrial sectors. However, recent stock performance weakness (trading near CHF 8.86 as of Nov 2025) and negative EPS signals reflect execution challenges and market headwinds that warrant monitoring.
Top Insights
Market leader in high-precision delivery with 900+ active patents protecting competitive moat across healthcare, industrial adhesives, and beauty care
Two-segment model (Healthcare and Consumer & Industrial) provides revenue diversification and exposure to both regulated medical device and industrial adhesive markets
Recent stock underperformance (5.68% dividend yield at CHF 8.86 price) suggests valuation opportunity but also signals investor concerns about growth trajectory
Sustainability leadership (CDP Rating B for climate change) demonstrates ESG commitment and appeals to institutional healthcare investors
Named Competitors
Medical Device Delivery Systems — Orthopedic and tissue regeneration devices
Adhesive Dispensing Systems — Two-component adhesive/sealant mixing and application
Beauty Applicators — Micro-brushes for cosmetics and skincare
Recent Developments
(November 2023) Production site inauguration in Valencia, Spain with 14,000+ sqm facility and 200+ employees to serve adhesive/sealant customers
(2024) Market cap stood at CHF 363.1M as of December 31, reflecting slight recovery from earlier 2025 lows
(2025) Received CDP Rating B for climate change, positioning in top tier above industry average (C rating)
Open the full interactive Medmix AG report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.